Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders

Archives of General Psychiatry

Volumn 68, Issue 3, 2011, Pages 306-313

  Suzuki, Katsuaki ^a   Sugihara, Genichi ^a   Ouchi, Yasuomi ^a,b   Nakamura, Kazuhiko ^a   Tsujii, Masatsugu ^d   Futatsubashi, Masami ^b   Iwata, Yasuhide ^a   Tsuchiya, Kenji J ^a   Matsumoto, Kaori ^a   Takebayashi, Kiyokazu ^a   Wakuda, Tomoyasu ^a   Yoshihara, Yujiro ^e   Suda, Shiro ^a   Kikuchi, Mitsuru ^c   Takei, Nori ^a   Sugiyama, Toshirou ^a   Irie, Toshiaki ^f   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d CHUKYO UNIVERSITY   (Japan)

^e Koujin Hospital   (Japan)

^f NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CARBON 11; N METHYL 4 PIPERIDYLACETATE C 11; PIPERIDINE DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTISM; BRAIN REGION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUSIFORM GYRUS; HUMAN; INFANTILE AUTISM; INTELLIGENCE QUOTIENT; MALE; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; SOCIAL DISABILITY; SOCIAL INTERACTION; STATISTICAL SIGNIFICANCE;

ACETATES; ACETYLCHOLINESTERASE; ADOLESCENT; ADULT; BRAIN MAPPING; CARBON RADIOISOTOPES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMMUNICATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; SOCIAL BEHAVIOR; STEREOTYPED BEHAVIOR; TEMPORAL LOBE; YOUNG ADULT;

EID: 79952349605     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.4     Document Type: Article

References (58)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Grelotti DJ, Gauthier I, Schultz RT. Social interest and the development of cortical face specialization: what autism teaches us about face processing. Dev Psychobiol. 2002;40(3):213-225. (Pubitemid 34651290)
3. Schultz RT. Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci. 2005;23(2-3):125-141. (Pubitemid 40313547)
4. George N, Dolan RJ, Fink GR, Baylis GC, Russell C, Driver J. Contrast polarity and face recognition in the human fusiform gyrus. Nat Neurosci. 1999;2(6): 574-580. (Pubitemid 30491240)
5. Kanwisher N, Stanley D, Harris A. The fusiform face area is selective for faces not animals. Neuroreport. 1999;10(1):183-187. (Pubitemid 29090504)
6. Kanwisher N, McDermott J, Chun MM. The fusiform face area: a module in human extrastriate cortex specialized for face perception. J Neurosci. 1997;17 (11):4302-4311. (Pubitemid 27220621)
7. Golarai G, Grill-Spector K, Reiss AL. Autism and the development of face processing. Clin Neurosci Res. 2006;6(3):145-160. (Pubitemid 44567519)
8. Critchley HD, Daly EM, Bullmore ET, Williams SC, Van Amelsvoort T, Robertson DM, Rowe A, Phillips M, Mc Alonan G, Howlin P, Murphy DG. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain. 2000;123(pt 11):2203-2212.
9. Pierce K, Müller RA, Ambrose J, Allen G, Courchesne E. Face processing occurs outside the fusiform 'face area' in autism: evidence from functional MRI. Brain. 2001;124(pt 10):2059-2073.
10. Schultz RT, Gauthier I, Klin A, Fulbright RK, Anderson AW, Volkmar F, Skudlarski P, Lacadie C, Cohen DJ, Gore JC. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry. 2000;57(4):331-340. (Pubitemid 30202323)
11. Piggot J, Kwon H, Mobbs D, Blasey C, Lotspeich L, Menon V, Bookheimer S, Reiss AL. Emotional attribution in high-functioning individuals with autistic spectrum disorder: a functional imaging study. J Am Acad Child Adolesc Psychiatry. 2004;43(4):473-480. (Pubitemid 38812388)
12. Wang AT, Lee SS, Sigman M, Dapretto M. Reading affect in the face and voice: neural correlates of interpreting communicative intent in children and adolescents with autism spectrum disorders. Arch Gen Psychiatry. 2007;64(6):698-708. (Pubitemid 46878670)
13. Pierce K, Haist F, Sedaghat F, Courchesne E. The brain response to personally familiar faces in autism: findings of fusiform activity and beyond. Brain. 2004; 127(pt 12):2703-2716. (Pubitemid 39627379)
14. Pierce K, Redcay E. Fusiform function in children with an autism spectrum disorder is a matter of "who". Biol Psychiatry. 2008;64(7):552-560.
15. Dalton KM, Nacewicz BM, Johnstone T, Schaefer HS, Gernsbacher MA, Goldsmith HH, Alexander AL, Davidson RJ. Gaze fixation and the neural circuitry of face processing in autism. Nat Neurosci. 2005;8(4):519-526. (Pubitemid 41007571)
16. DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J, Young LJ. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006;26(26):6897-6906. (Pubitemid 44309856)
17. van Kooten IA, Palmen SJ, von Cappeln P, Steinbusch HW, Korr H, Heinsen H, Hof PR, van Engeland H, Schmitz C. Neurons in the fusiform gyrus are fewer and smaller in autism. Brain. 2008;131(pt 4):987-999. (Pubitemid 351499430)
18. Robertson RT, Gallardo KA, Claytor KJ, Ha DH, Ku KH, Yu BP, Lauterborn JC, Wiley RG, Yu J, Gall CM, Leslie FM. Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons. Cereb Cortex. 1998;8(2):142-155. (Pubitemid 28134396)
19. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience. 2002;111(4):815-835. (Pubitemid 34603251)
20. Rosier AM, Cornette L, Dupont P, Bormans G, Mortelmans L, Orban GA. Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding. Eur J Neurosci. 1999;11(10):3701-3714.
21. Schon K, Atri A, Hasselmo ME, Tricarico MD, LoPresti ML, Stern CE. Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. J Neurosci. 2005;25 (40):9112-9123. (Pubitemid 41500819)
22. Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert M. Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A. 2002;99(1):455-460. (Pubitemid 34060382)
23. Thiel CM, Henson RN, Dolan RJ. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacology. 2002;27(2):282-292. (Pubitemid 34686979)
24. Bentley P, Vuilleumier P, Thiel CM, Driver J, Dolan RJ. Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage. 2003;20(1):58-70. (Pubitemid 37188499)
25. Bohnen NI, Frey KA. Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders. Mol Imaging Biol. 2007;9(4):243-257. (Pubitemid 47028740)
26. Irie T, Fukushi K, Akimoto Y, Tamagami H, Nozaki T. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl Med Biol. 1994;21(6):801-808. (Pubitemid 24263573)
27. Iyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, Sudo Y, Suzuki K, Irie T. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet. 1997;349(9068):1805-1809. (Pubitemid 27258658)
28. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry. 2001;158(7):1058-1066. (Pubitemid 32623109)
29. American Psychiatric Association. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version. Washington, DC: American Psychiatric Press; 1997.
30. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000;30(3):205-223.
31. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659-685. (Pubitemid 24309810)
32. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010;67(1):59-68.
33. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry. 2006;63(1):90-100. (Pubitemid 43037473)
34. Herholz K, Lercher M, Wienhard K, Bauer B, Lenz O, Heiss WD. PET measurement of cerebral acetylcholine esterase activity without blood sampling. Eur J Nucl Med. 2001;28(4):472-477. (Pubitemid 32260913)
35. 11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling. J Cereb Blood Flow Metab. 2001;21(11):1354-1366.
36. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S, Flowers L, Wood F, Maldjian JA. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage. 2007;34(1):137-143. (Pubitemid 44765265)
37. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using amacroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273-289. (Pubitemid 34852226)
38. Heckers S, Geula C, Mesulam MM. Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease. Neurobiol Aging. 1992;13(4):455-460.
39. Mesulam MM, Geula C. Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution. J Comp Neurol. 1991;306(2):193-220.
40. Hutsler JJ, Gazzaniga MS. Acetylcholinesterase staining in human auditory and language cortices: regional variation of structural features. Cereb Cortex. 1996; 6(2):260-270. (Pubitemid 26117402)
41. Mesulam MM. The cholinergic innervation of the human cerebral cortex. Prog Brain Res. 2004;145:67-78.
42. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121(pt 12):2249-2257. (Pubitemid 28552464)
43. Baron-Cohen S, Jolliffe T, Mortimore C, Robertson M. Another advanced test of theory of mind: evidence from very high functioning adults with autism or asperger syndrome. J Child Psychol Psychiatry. 1997;38(7):813-822. (Pubitemid 27480923)
44. Nacewicz BM, Dalton KM, Johnstone T, Long MT, McAuliff EM, Oakes TR, Alexander AL, Davidson RJ. Amygdala volume and nonverbal social impairment in adolescent and adult males with autism. Arch Gen Psychiatry. 2006;63(12): 1417-1428. (Pubitemid 44878525)
45. Kleinhans NM, Richards T, Sterling L, Stegbauer KC, Mahurin R, Johnson LC, Greenson J, Dawson G, Aylward E. Abnormal functional connectivity in autism spectrum disorders during face processing. Brain. 2008;131(pt 4):1000-1012. (Pubitemid 351499416)
46. Krnjević K, Silver A. A histochemical study of cholinergic fibres in the cerebral cortex. J Anat. 1965;99(pt 4):711-759.
47. Levey AI, Wainer BH, Rye DB, Mufson EJ, Mesulam MM. Choline acetyltransferase-immunoreactive neurons intrinsic to rodent cortex and distinction from acetylcholinesterase- positive neurons. Neuroscience. 1984;13(2):341-353. (Pubitemid 15211944)
48. McCormick DA, Williamson A. Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc Natl Acad Sci U S A. 1989;86(20):8098-8102. (Pubitemid 19265327)
49. Mesulam MM, Rosen AD, Mufson EJ. Regional variations in cortical cholinergic innervation: chemoarchitectonics of acetylcholinesterase-containing fibers in the macaque brain. Brain Res. 1984;311(2):245-258. (Pubitemid 14023376)
50. Mrzljak L, Levey AI, Goldman-Rakic PS. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A. 1993;90(11):5194-5198. (Pubitemid 23183004)
51. Schröder H, Zilles K, Luiten PGM, Strosberg AD. Immunocytochemical visualization of muscarinic cholinoceptors in the human cerebral cortex. Brain Res. 1990;514(2):249-258. (Pubitemid 20151376)
52. Höhmann CF, Kwiterovich KK, Oster-Granite ML, Coyle JT. Newborn basal forebrain lesions disrupt cortical cytodifferentiation as visualized by rapid Golgi staining. Cereb Cortex. 1991;1(2):143-157.
53. Siciliano R, Fontanesi G, Casamenti F, Berardi N, Bagnoli P, Domenici L. Postnatal development of functional properties of visual cortical cells in rats with excitotoxic lesions of basal forebrain cholinergic neurons. Vis Neurosci. 1997;14(1):111-123. (Pubitemid 27415951)
54. Kuczewski N, Aztiria E, Gautam D, Wess J, Domenici L. Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice. J Physiol. 2005;566(pt 3):907-919. (Pubitemid 41122670)
55. Leroy C, Comtat C, Trébossen R, Syrota A, Martinot JL, Ribeiro MJ. Assessment of 11C-PE2I binding to the neuronal dopamine transporter in humans with the high-spatial-resolution PET scanner HRRT. J Nucl Med. 2007;48(4):538-546. (Pubitemid 47571407)
56. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005;57(2):168-175. (Pubitemid 40179853)
57. Dziobek I, Bahnemann M, Convit A, Heekeren HR. The role of the fusiformamygdala system in the pathophysiology of autism. Arch Gen Psychiatry. 2010;67(4):397-405.
58. Chételat G, Desgranges B, Landeau B, Mézenge F, Poline JB, de la Sayette V, Viader F, Eustache F, Baron JC. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain. 2008;131 (pt 1):60-71.